case_images: PMC10579556_01
case_images: Rash (A); Deformities of the knee (B); X-ray showing destruction of patella (C); X-ray of the knee were taken half a year after Canakinumab treatment (D).
case_images: fimmu-14-1238551-g001.jpg
case_images: PMC10579556_02_fimmu-14-1238551-g001.jpg
case_images: f1
case_images: In addition, the patient exhibited features such as a prominent forehead, flat nose bridge, rough skin, an unclosed anterior fontanelle, and enlarged knee joints ( Figure 1B ). The DR of the knees revealed patella bone destruction ( Figure 1C ). However, patellar bone destruction did not improve after half a year of Canakinumab treatment, and it merely showed a reduction in the soft tissue swelling around the knee joint ( Figure 1D ).
case_images: PMC10579556_02
case_images: Rash (A); Deformities of the knee (B); X-ray showing destruction of patella (C); X-ray of the knee were taken half a year after Canakinumab treatment (D).
case_images: fimmu-14-1238551-g001.jpg
case_images: PMC10579556_02_fimmu-14-1238551-g001.jpg
case_images: f1
case_images: In addition, the patient exhibited features such as a prominent forehead, flat nose bridge, rough skin, an unclosed anterior fontanelle, and enlarged knee joints ( Figure 1B ). The DR of the knees revealed patella bone destruction ( Figure 1C ). However, patellar bone destruction did not improve after half a year of Canakinumab treatment, and it merely showed a reduction in the soft tissue swelling around the knee joint ( Figure 1D ).
case_images: Interstitial lung disease in the left lung, the red snip point (A), Pulmonary CT after eight months of Canakinumab treatment (B).
case_images: fimmu-14-1238551-g002.jpg
case_images: PMC10579556_02_fimmu-14-1238551-g002.jpg
case_images: f2
case_images: A chest CT scan showed interstitial lung disease in the left lung ( Figure 2A ), but she had no respiratory symptoms. Pulmonary CT showed that the interstitial changes of the left lung were slightly reduced after eight months of Canakinumab treatment ( Figure 2B ).